hexasoptin retard 120 mg depotkapsler, hårde
sandoz a/s - verapamilhydrochlorid - depotkapsler, hårde - 120 mg
verapamil "hexal" 120 mg filmovertrukne tabletter
hexal a/s - verapamilhydrochlorid - filmovertrukne tabletter - 120 mg
verapamil "hexal" 40 mg filmovertrukne tabletter
hexal a/s - verapamilhydrochlorid - filmovertrukne tabletter - 40 mg
verapamil "hexal" 80 mg filmovertrukne tabletter
hexal a/s - verapamilhydrochlorid - filmovertrukne tabletter - 80 mg
verapamil "nordic prime" 80 mg filmovertrukne tabletter
nordic prime aps - verapamilhydrochlorid - filmovertrukne tabletter - 80 mg
fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptika, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
verapamil "2care4" 120 mg filmovertrukne tabletter
2care4 aps - verapamilhydrochlorid - filmovertrukne tabletter - 120 mg
scemblix
novartis europharm limited - asciminib hydrochloride - leukæmi, myelogen, kronisk, bcr-abl positiv - antineoplastiske midler - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
elfabrio
chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry disease - andre alimentary tract and metabolism produkter, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).
quartz es suspensionskoncentrat
2022 environmental science fr s.a.s. - diflufenican - suspensionskoncentrat - 500 g/l diflufenican